Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness

NCT05172063 is registered in ClinicalTrials.gov with Children's Cancer Hospital Egypt 57357 as lead sponsor.

NCT NCT05172063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05172063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness
Lead sponsor
Children's Cancer Hospital Egypt 57357
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2022
Completion date
December 31, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

children with cancer, sars-cov-2 infection